Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Pain in ROP Screening
NCT06067958Phase 3Recruiting
- Sponsor
- Shamir Medical Center
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in procedural pain, sponsored by Shamir Medical Center. Started Dec 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06067958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06067958.